Based on our preliminary observations regarding MMP-2 processing of LTBP-3, we hypothesize that osteoblast derived MMP-2 is a key mediator of TGFβ activation in the tumor-bone microenvironment. The gene discussed is LTBP3; the disease is neoplasm.